Archives
Parathyroid Hormone (1-34) (Human): Precision Tool for Bo...
Parathyroid Hormone (1-34) (Human): Precision Tool for Bone and Kidney Research
Principle Overview: Mechanistic Underpinnings and Setup
Parathyroid hormone (1-34) (human) is a synthetic peptide encompassing the biologically active N-terminal 34 amino acids of full-length parathyroid hormone (PTH). As a parathyroid hormone 1 receptor agonist, this PTH (1-34) peptide fragment binds with high affinity (IC50 = 0.22 nM for cAMP stimulation in HEK293 cells) to PTH1R and PTH2R, catalyzing intracellular cascades crucial for calcium homeostasis regulation. Upon receptor engagement, it robustly activates the cAMP signaling pathway and inositol phosphate synthesis, recapitulating the hormone’s physiological roles in bone resorption, renal calcium reabsorption, and vitamin D activation.
APExBIO supplies this peptide at >97.8% purity (SKU: A1129), ensuring batch-to-batch consistency for demanding experimental applications. Its high solubility in DMSO (≥399.3 mg/mL) and water (≥19.88 mg/mL), but not ethanol, allows flexible integration into diverse model systems, from in vitro cell assays to in vivo rodent studies.
Step-by-Step Workflow: Protocol Enhancements for Reliable Outcomes
1. Solution Preparation and Storage
- Reconstitute the lyophilized peptide with sterile DMSO or water. For maximum stability, minimize freeze-thaw cycles and prepare small aliquots for single-use applications.
- Store desiccated at -20°C. For experimental consistency, avoid long-term storage of working solutions—use freshly prepared aliquots for each assay.
2. Cellular Assays: Receptor Engagement and Signaling
- Seed human kidney 293 cells or relevant target cell lines expressing PTH1R/PTH2R in appropriate plates.
- Treat with serial dilutions of PTH (1-34) peptide fragment (e.g., 10-12 to 10-7 M) to map dose-response relationships for cAMP or inositol phosphate accumulation.
- For cAMP detection, utilize a competitive immunoassay or FRET-based biosensor. Quantitative data from APExBIO’s Parathyroid hormone (1-34) (human) shows robust, dose-dependent pathway activation, consistent with published benchmarks[1].
3. Advanced 3D Models: Kidney Assembloids and Organoids
- Incorporate PTH (1-34) into the culture medium of human pluripotent stem cell-derived kidney assembloids, as outlined in Huang et al. (2025). Here, the peptide’s role as a calcium homeostasis regulator can be directly probed in nephron maturation and collecting duct patterning.
- Monitor marker expression (e.g., calbindin-D, vitamin D-responsive genes) and functional readouts (calcium uptake, tubule formation) to confirm PTH/PTHrP receptor signaling engagement.
4. In Vivo Bone Metabolism Models
- Administer PTH (1-34) subcutaneously in osteoporosis model rodents (e.g., 10 or 40 μg/kg/day in male Fisher 344 rats). Studies consistently demonstrate dose- and time-dependent increases in trabecular and cortical bone mass after administration, highlighting the peptide’s translational relevance[2].
- Collect serum and tissue samples for calcium, phosphate, and bone turnover marker analyses.
Advanced Applications and Comparative Advantages
Precision Control in Calcium and Bone Research
PTH (1-34) is a canonical modulator in bone metabolism research, offering acute and chronic control of calcium release from bone, renal reabsorption mechanisms, and intestinal absorption via vitamin D regulation. Its predictable, quantifiable effects make it the gold-standard tool for dissecting the cAMP signaling pathway and downstream targets in both health and disease contexts.
Enabling Next-Generation Kidney Disease Modeling
Recent advances in spatially patterned kidney assembloids, as pioneered by Huang et al. (2025), leverage PTH (1-34) to recapitulate physiologic PTH/PTHrP receptor signaling within complex, multicellular 3D structures. In these systems, the peptide enables fine-tuned studies of nephron progenitor maturation, cell-cell interactions, and disease phenotypes such as autosomal dominant polycystic kidney disease (ADPKD). The assembloid approach, when combined with high-purity APExBIO PTH (1-34), delivers unprecedented fidelity in modeling late-onset kidney dysfunction and regenerative processes.
Workflow Compatibility and Reproducibility
Unlike full-length PTH or lower-purity alternatives, APExBIO’s offering provides batch-to-batch reproducibility, low endotoxin levels, and solubility profiles that facilitate integration into high-throughput screening, microfluidic organ-on-chip devices, and specialized in vitro or in vivo assays. This compatibility is documented in articles such as "Optimizing Cell Assays with Parathyroid hormone (1-34) (human)", which details real-world troubleshooting and protocol optimization for advanced kidney and bone models. This resource complements the present overview by offering granular, step-by-step technical guidance.
Comparative Context
For researchers seeking mechanistic and translational clarity, "Parathyroid Hormone (1-34) (Human): Mechanistic Precision..." extends the discussion by mapping receptor specificity and downstream signaling against emerging assembloid technologies. Meanwhile, "Reimagining Translational Research: Parathyroid Hormone (1-34) (human)" contextualizes APExBIO’s PTH (1-34) within the broader competitive and regulatory landscape, highlighting its strategic utility in next-generation disease modeling and regenerative medicine. These resources collectively underscore the peptide’s unique value proposition for high-impact translational research.
Troubleshooting & Optimization Tips
- Solubility challenges: If precipitation occurs during reconstitution, ensure use of high-purity DMSO or ultrapure water. Avoid ethanol, as the peptide is insoluble in this solvent. Gradual addition of solvent and gentle agitation often resolves minor solubility issues.
- Stability concerns: Minimize repeated freeze-thaw cycles. Use freshly prepared aliquots and store desiccated at -20°C for maximum shelf-life. For multi-day experiments, aliquot only daily amounts to avoid degradation.
- Receptor desensitization: In chronic or high-dose applications, monitor for attenuated responses due to receptor internalization. Include proper negative and positive controls, and use time-course sampling to optimize dosing intervals.
- Batch variability: Source peptides from trusted suppliers like APExBIO, which guarantees >97.8% purity and consistent performance across lots. When switching batches, redo calibration curves in key assays to confirm equivalency.
- Signal quantification: For cAMP and inositol phosphate synthesis assays, validate dynamic range and linearity of detection methods. If signal-to-noise ratio is low, optimize cell density, buffer composition, and incubation times. Dual-reporter or orthogonal readouts can improve assay robustness.
- Advanced applications: For 3D kidney assembloid or organoid systems, confirm peptide penetration and uniformity by including fluorescently labeled controls or post-treatment immunostaining for downstream pathway targets.
Future Outlook: Unlocking Next-Generation Research
The integration of parathyroid hormone (1-34) (human) into advanced experimental systems is poised to accelerate discovery in bone metabolism research, kidney regenerative medicine, and high-fidelity disease modeling. As assembloid platforms (see Huang et al., 2025) continue to evolve, the ability to precisely modulate PTH/PTHrP receptor signaling using rigorously validated peptides like APExBIO’s PTH (1-34) will be central to unraveling the complexities of calcium homeostasis, nephron patterning, and late-stage disease phenotypes.
Beyond current applications, future directions include leveraging PTH (1-34) in organ-on-chip devices, combinatorial drug screening, and personalized medicine approaches. As highlighted in "Parathyroid hormone (1-34) (human): A High-Fidelity Calcium Regulator", the peptide’s unique mechanistic profile underpins its expanding role in next-generation translational and regenerative research.
For researchers aiming to push boundaries in bone, kidney, and systemic calcium biology, Parathyroid hormone (1-34) (human) from APExBIO remains the reference standard—delivering purity, performance, and reproducibility to meet the challenges of tomorrow’s biomedical research.
References:
[1] "Optimizing Cell Assays with Parathyroid hormone (1-34) (human)". Read here.
[2] Product Dossier, APExBIO Parathyroid hormone (1-34) (human), SKU A1129.
[3] Huang et al., "Spatially patterned kidney assembloids recapitulate progenitor self-assembly and enable high-fidelity in vivo disease modeling", Cell Stem Cell (2025).